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background:  Circulating progenitor cells (PCs) are mobilized in response to myocardial injury and reflect reparative/regenerative potential. We 
hypothesized that the degree of PC mobilization differs between different acute coronary syndrome (ACS) presentations.
methods: We recruited 90 ACS patients (mean age 65±15 years). Nine patients with STEMI, 69 with NSTEMI and 12 with unstable angina were 
compared to 180 age- and gender-matched subjects with stable coronary artery disease (CAD). Blood samples were obtained for enumeration of 
PCs as CD45 dim mononuclear cells by flow cytometry with cells expressing CD34 and CD133 epitopes representing hematopoietic PCs and those 
expressing vascular endothelial growth factor receptor (VEGF2R) representing endothelial-enriched PCs. Mann-Whitney nonparametric test was used 
to compare differences in PCs between groups.
results: Endothelial-enriched PC levels were higher in patients with STEMI compared to other groups (Table 1) and correlated with peak troponin 
levels in ACS (CD34+/VEGF2R+: r=0.28, p=0.012; CD34+/CXCR4+/VEGF2R+: r=0.29, p=0.009). These findings persisted after analysis of covariance 
to account for age, gender, diabetes, smoking status, and statin use.
Conclusions: These results suggest endothelial-enriched PCs are mobilized proportionately to the magnitude of myocardial damage in subjects 
with ACS while hematopoietic PCs remain unchanged. Whether the magnitude of PC response to injury relates to outcomes remains to be studied. 
 
Table 1. Mean circulating progenitor cell levels by ACS category
Circulating Progenitor 
Cells
Mean PC levels ± standard deviation (cells/µL) P-values
STEMI
(N=9)
NSTEMI
(N=69)
Unstable 
Angina
(N=12)
Stable CAD
(N=180)
STEMI vs. NSTEMI
STEMI vs. 
Unstable Angina
STEMI vs. 
Stable CAD
CD34+ 2.94±1.80 2.78±3.43 2.02±1.10 2.25±1.80 0.37 0.27 0.17
CD34+/CD133+ 1.36±0.84 1.22±1.15 0.92±0.49 1.07±1.01 0.35 0.19 0.14
CD34+/VEGF2R+ 0.37±0.38 0.22±0.21 0.09±0.07 0.18±0.16 0.11 0.003 0.037
CD34+/CXCR4+/VEGF2R+ 0.37±0.38 0.21±0.21 0.08±0.07 0.17±0.15 0.08 0.003 0.030
